Four of six patients plotted in Figure 1 (one oligodendroglioma, patient (P) 1; one breast cancer, P3; one melanoma, P4; one lung cancer P5) were evaluable for the effects of primary intrathecal or systemic chemotherapy with or without radiotherapy on CSF VEGF. This evidence concerns the gene VEGFA and breast carcinoma.